AstraZeneca Rumored to Bid €176 Per Share for French Biotech Abivax Amid M&A Buzz
Abivax shares jump 6% on reports of AstraZeneca's €176-per-share offer for the French inflammatory disease drugmaker, adding to ongoing acquisition speculation.
NOTRELOAD AI
Valneva Withdraws Chikungunya Vaccine from U.S. Market
Valneva voluntarily withdraws its IXCHIQ chikungunya vaccine from the U.S. following FDA suspension and a serious adverse event report, while maintaining licenses in Europe, Canada, UK, and Brazil.
GSK Acquires RAPT Therapeutics for $2.2 Billion to Develop New Food Allergy Treatment
GSK purchases RAPT Therapeutics for $2.2B, gaining ozureprubart - a promising food allergy treatment requiring injections every 12 weeks instead of every 2 weeks.
Apple Reclaims China's Top Spot as iPhone Sales Surge Despite Memory Chip Crisis
Apple's iPhone shipments jumped 28% in China's holiday quarter, overtaking rivals despite worsening memory chip shortages that threaten industry margins.
Prediction Markets Slam Sports Betting Stocks as DraftKings, Flutter Plunge
DraftKings and Flutter shares tumble as prediction market platforms Kalshi and Polymarket surge during NFL playoffs, threatening traditional sportsbook dominance with $720M in weekly volume.
Beyond Meat Launches Protein Drinks Amid Declining Sales
Beyond Meat introduces carbonated protein drinks through its test kitchen as plant-based meat sales decline. Experts question whether the brand can successfully expand beyond meat alternatives.